Last updated: February 25, 2025
Sponsor: University of Colorado, Denver
Overall Status: Active - Recruiting
Phase
N/A
Condition
Esophageal Cancer
Esophageal Disorders
Barrett's Esophagus
Treatment
Endoscopic eradication therapies (EET)
Chemotherapy
Esophagectomy
Clinical Study ID
NCT02634645
14-2371
Ages 18-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with Barrett's related neoplasia and dysplasia. Patients with esophagealcancer
Exclusion
Exclusion Criteria:
- Patients with squamous cell carcinoma
Study Design
Total Participants: 5000
Treatment Group(s): 4
Primary Treatment: Endoscopic eradication therapies (EET)
Phase:
Study Start date:
January 01, 2015
Estimated Completion Date:
January 31, 2027
Study Description
Connect with a study center
UCLA Medical Center
Los Angeles, California 90095
United StatesActive - Recruiting
Moffitt Cancer Center
Tampa, Florida 33612
United StatesActive - Recruiting
Northwestern Memorial Hospital
Chicago, Illinois 60611
United StatesActive - Recruiting
Washington University
Saint Louis, Missouri 63130
United StatesSite Not Available
Washington University
St. Louis, Missouri 63130
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.